Cost Implications of Escalating Intravenous Acetaminophen Use in Children

JAMA Pediatr. 2019 May 1;173(5):489-491. doi: 10.1001/jamapediatrics.2019.0101.

Florence T Bourgeois^{1

2}, Dionne A Graham^{2

3}, Aaron S Kesselheim⁴, Adrienne G Randolph^{5

6}

¹ Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, Massachusetts.
² Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
³ Center for Applied Pediatric Quality Analytics, Boston Children's Hospital, Boston, Massachusetts.
⁴ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
⁵ Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
⁶ Department of Anaesthesiology, Harvard Medical School, Boston, Massachusetts.

Abstract

This study examines the use of intravenous acetaminophen in children and its rising costs.